3D Medicines Inc. (HKG:1244)
Hong Kong · Delayed Price · Currency is HKD 2.160
-0.080 (-3.57%)
Jul 31, 2026, 2:03 PM HKT
3D Medicines Market Cap
3D Medicines has a market cap or net worth of 531.19 million as of July 31, 2026. Its market cap has decreased by -69.80% in one year.
Market Cap
531.19M
Enterprise Value
156.19M
Revenue
396.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.16
ChartMarket Cap Chart
Since December 15, 2022, 3D Medicines's market cap has decreased from 7.02B to 531.19M, a decrease of -92.44%. That is a compound annual growth rate of -50.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 531.19M | -59.39% |
| Dec 31, 2025 | 1.31B | 73.29% |
| Dec 31, 2024 | 754.73M | -56.44% |
| Dec 29, 2023 | 1.73B | -81.75% |
| Dec 30, 2022 | 9.49B | 35.14% |
| Dec 15, 2022 | 7.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sunho Biologics | 970.43M |
| Cutia Therapeutics | 850.28M |
| Kintor Pharmaceutical | 839.48M |
| Wuhan YZY Biopharma | 715.30M |
| Brii Biosciences | 678.50M |
| JW (Cayman) Therapeutics Co. | 653.49M |
| Shanghai Bio-heart Biological Technology | 552.56M |
| Transcenta Holding | 460.78M |